These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 936113)

  • 1. Platelet glycocalicin: a single receptor for platelet aggregation induced by thrombin or ristocetin.
    Okumura T; Jamieson GA
    Thromb Res; 1976 May; 8(5):701-6. PubMed ID: 936113
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies against platelet membrane glycoproteins. I. Crossed immunoelectrophoresis studies with antibodies that inhibit ristocetin-induced platelet aggregation.
    Ali-Briggs EF; Clemetson KJ; Jenkins CS
    Br J Haematol; 1981 Jun; 48(2):305-18. PubMed ID: 7236528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against platelet membrane glycoproteins. III. Effect on thrombin-and bovine Von Willebrand factor-induced aggregation.
    Jenkins CS; Clemetson KJ; Ali-Briggs EF
    Br J Haematol; 1983 Mar; 53(3):491-501. PubMed ID: 6600621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and reversal of ristocetin - induced platelet aggregation.
    Howard MA
    Thromb Res; 1975 Jun; 6(6):489-99. PubMed ID: 239463
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoinhibition of ristocetin-induced platelet aggregation.
    Nachman RL; Jaffe EA; Weksler BB
    J Clin Invest; 1977 Jan; 59(1):143-8. PubMed ID: 299747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha 1-acid glycoprotein on ristocetin, thrombin and Polybrene induced platelet aggregation.
    Coller BS
    Thromb Res; 1980 May 1-15; 18(3-4):579-84. PubMed ID: 6774438
    [No Abstract]   [Full Text] [Related]  

  • 7. Aromatic tetra-amidines with antiproteolytic activity inhibit platelet aggregation and secretion.
    Milani L; Ferroni R; Zaccarini M; Traniello S
    Thromb Res; 1989 Nov; 56(3):417-24. PubMed ID: 2515612
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of platelet glycocalicin by affinity chromatography on thrombin-sepharose.
    Moroi M; Goetze A; Dubay E; Wu C; Hasitz M; Jamieson GA
    Thromb Res; 1982 Oct; 28(1):103-14. PubMed ID: 7157225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Drug inhibition of ristocetin-induced platelet aggregation.
    Tann G; Flute PT
    Thromb Diath Haemorrh; 1975 Sep; 34(1):340-1. PubMed ID: 1188776
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin and ristocetin-induced platelet aggregation.
    Pekçelen Y; Inceman S
    Thromb Haemost; 1976 Apr; 35(2):485-7. PubMed ID: 989644
    [No Abstract]   [Full Text] [Related]  

  • 12. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of platelet glycocalicin.
    Jamieson GA; Okumura T; Hasitz M
    Thromb Haemost; 1980 Feb; 42(5):1673-8. PubMed ID: 7368163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Heparin and ristocetin-reduced platelet aggregation.
    Pekcelen Y; Inceman S
    Br Med J; 1975 Oct; 4(5988):101-2. PubMed ID: 1182460
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Inhibition of ristocetin-induced platelet aggregation (RIPA) by Haemaccel and fibrinogen.
    Stibbe J; Kirby E
    Thromb Diath Haemorrh; 1975 Nov; 34(2):583. PubMed ID: 1198487
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversibility of thrombin-induced decrease in platelet glycoprotein Ib function.
    Lu H; Menashi S; Garcia I; Cramer EM; Li H; Tenza D; De Romeuf C; Soria J; Soria C
    Br J Haematol; 1993 Sep; 85(1):116-23. PubMed ID: 8251378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of Haemaccel, fibrinogen and albumin on ristocetin-induced platelet aggregation. Relevance to the quantitative measurement of the ristocetin cofactor.
    Stibbe J; Kirby EP
    Thromb Res; 1976 Feb; 8(2):151-65. PubMed ID: 1251347
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
    Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
    Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations.
    Yamamoto N; Kitagawa H; Tanoue K; Yamazaki H
    Thromb Res; 1985 Sep; 39(6):751-9. PubMed ID: 2417361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.